[go: up one dir, main page]

CN118546395A - Preparation method of polysaccharide sodium hyaluronate composite gel - Google Patents

Preparation method of polysaccharide sodium hyaluronate composite gel Download PDF

Info

Publication number
CN118546395A
CN118546395A CN202410647177.4A CN202410647177A CN118546395A CN 118546395 A CN118546395 A CN 118546395A CN 202410647177 A CN202410647177 A CN 202410647177A CN 118546395 A CN118546395 A CN 118546395A
Authority
CN
China
Prior art keywords
gel
sodium hyaluronate
molecular weight
polysaccharide
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202410647177.4A
Other languages
Chinese (zh)
Other versions
CN118546395B (en
Inventor
张玲芝
左海燕
陆星婷
曹铭
颜杰峰
孟媛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Ruihua Bioengineering Co ltd
Original Assignee
Zhuhai Ruihua Bioengineering Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Ruihua Bioengineering Co ltd filed Critical Zhuhai Ruihua Bioengineering Co ltd
Priority to CN202410647177.4A priority Critical patent/CN118546395B/en
Publication of CN118546395A publication Critical patent/CN118546395A/en
Application granted granted Critical
Publication of CN118546395B publication Critical patent/CN118546395B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/245Differential crosslinking of one polymer with one crosslinking type, e.g. surface crosslinking
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/247Heating methods
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

本发明涉及一种多糖透明质酸钠复合凝胶的制备方法,属于高分子材料制备技术领域。本发明的制备方法通过先在低温条件交联,然后在高温条件交联,制备得到多糖透明质酸钠复合凝胶。本发明提供的方法,能以最简单的操作、最快的时间得到弹性好且易注射的凝胶产品,重现性好,适合不同类型多糖透明质酸钠复合凝胶的制备,更加利于工业化生产。

The present invention relates to a method for preparing a polysaccharide sodium hyaluronate composite gel, and belongs to the technical field of polymer material preparation. The preparation method of the present invention prepares a polysaccharide sodium hyaluronate composite gel by first cross-linking under low temperature conditions and then cross-linking under high temperature conditions. The method provided by the present invention can obtain a gel product with good elasticity and easy injection with the simplest operation and the fastest time, has good reproducibility, is suitable for the preparation of different types of polysaccharide sodium hyaluronate composite gels, and is more conducive to industrial production.

Description

一种多糖透明质酸钠复合凝胶的制备方法A preparation method of polysaccharide sodium hyaluronate composite gel

技术领域Technical Field

本发明属于高分子材料制备技术领域,具体涉及一种多糖透明质酸钠复合凝胶的制备方法。The invention belongs to the technical field of polymer material preparation, and particularly relates to a method for preparing a polysaccharide sodium hyaluronate composite gel.

背景技术Background Art

透明质酸是由葡萄糖醛酸和氨基葡萄糖为双糖单位组成的直链高分子多糖,存在于皮肤、眼玻璃体、软骨、关节滑液等许多结缔组织中,并在其中起到保湿、营养、修复和预防损伤等生理作用,透明质酸一般为其钠盐,即透明质酸钠(Sodium Hyaluronate,以下简称为HA),溶于水,但不溶于有机溶剂。Hyaluronic acid is a straight-chain high-molecular polysaccharide composed of glucuronic acid and glucosamine as disaccharide units. It exists in many connective tissues such as skin, vitreous body, cartilage, synovial fluid, etc., and plays physiological roles in moisturizing, nourishing, repairing and preventing damage. Hyaluronic acid is generally in the form of its sodium salt, sodium hyaluronate (hereinafter referred to as HA), which is soluble in water but insoluble in organic solvents.

硫酸软骨素(Chondroitin Sulfate,以下简称为“CS”)广泛存在于各种动物组织中,尤其在软骨和结缔组织中含量丰富。Chondroitin sulfate (hereinafter referred to as "CS") is widely present in various animal tissues, especially in cartilage and connective tissue.

CN100582146C公开一种生物相容性交联凝胶的制备方法,通过先加入一种聚合物反应再补加另外一种或同种聚合物反应获得高聚物,其要在反应过程中不断的监控反应程度,要达到具体的聚合度才添加另一种或同种聚合物,操作繁琐,不利于工业化生产。CN100582146C discloses a method for preparing a biocompatible cross-linked gel, wherein a polymer is first added to react and then another or the same polymer is added to react to obtain a high polymer. The degree of reaction must be continuously monitored during the reaction, and another or the same polymer is added only when a specific degree of polymerization is reached. The operation is cumbersome and not conducive to industrial production.

本发明提供一种多糖透明质酸钠复合凝胶及其制备方法,其操作简单,不需要其他的添加剂即可获得较高的凝胶强度和较好的流动性的凝胶产物。The invention provides a polysaccharide sodium hyaluronate composite gel and a preparation method thereof. The operation is simple and a gel product with higher gel strength and better fluidity can be obtained without other additives.

因此本发明提供的一种多糖透明质酸钠复合凝胶的制备方法,适合工业化生产,更加具有市场价值和深远的实用意义。Therefore, the preparation method of the polysaccharide sodium hyaluronate composite gel provided by the present invention is suitable for industrial production and has greater market value and far-reaching practical significance.

发明内容Summary of the invention

针对以上技术背景,本发明提供了一种多糖透明质酸钠复合凝胶的制备方法,该方法为一种全新的适合工业化生产的方法。In view of the above technical background, the present invention provides a method for preparing a polysaccharide sodium hyaluronate composite gel, which is a new method suitable for industrial production.

本发明提供一种多糖透明质酸钠复合凝胶的制备方法,其包含以下步骤:The present invention provides a method for preparing a polysaccharide sodium hyaluronate composite gel, which comprises the following steps:

步骤1:将透明质酸钠溶于氢氧化钠水溶液,加入低分子多糖,交联剂,先在温度A反应,再在温度B交联反应,制备得到多糖透明质酸钠复合凝胶。Step 1: Dissolve sodium hyaluronate in sodium hydroxide aqueous solution, add low molecular weight polysaccharide and cross-linking agent, first react at temperature A, then cross-link at temperature B to prepare polysaccharide sodium hyaluronate composite gel.

所述步骤1中,可以在温度A反应24h~72h(小时),优选为36h~60h,进一步优选为48h~72h。In the step 1, the reaction can be carried out at temperature A for 24 hours to 72 hours, preferably 36 hours to 60 hours, and more preferably 48 hours to 72 hours.

所述步骤1中,可以在温度B反应1h~6h,优选为2h~5h。In the step 1, the reaction can be carried out at temperature B for 1 h to 6 h, preferably 2 h to 5 h.

根据本发明,步骤1中所述的温度A可以为0℃至20℃,优选为5℃至15℃或8℃~12℃。According to the present invention, the temperature A in step 1 may be 0°C to 20°C, preferably 5°C to 15°C or 8°C to 12°C.

根据本发明,步骤1所述的温度B可以为25℃至50℃,优选为25℃至45℃,更优选为30℃至40℃。According to the present invention, the temperature B in step 1 may be 25°C to 50°C, preferably 25°C to 45°C, and more preferably 30°C to 40°C.

根据本发明,所述低分子多糖选自透明质酸钠(HA)、硫酸软骨素(CS)、软骨素(C)、肝素、纤维素中的一种或多种,优选透明质酸钠、硫酸软骨素、软骨素中的一种或多种。According to the present invention, the low molecular weight polysaccharide is selected from one or more of sodium hyaluronate (HA), chondroitin sulfate (CS), chondroitin (C), heparin, and cellulose, preferably one or more of sodium hyaluronate, chondroitin sulfate, and chondroitin.

步骤1中,所述的透明质酸钠与低分子多糖的质量比可以为(1~9):1,优选为(1~6):1。In step 1, the mass ratio of sodium hyaluronate to low molecular weight polysaccharide can be (1-9):1, preferably (1-6):1.

步骤1中,所述透明质酸钠的分子量范围可以为1×106至3×106Da,优选为2×106至3×106Da。In step 1, the molecular weight of the sodium hyaluronate may be in the range of 1×10 6 to 3×10 6 Da, preferably 2×10 6 to 3×10 6 Da.

步骤1中,所述的低分子多糖的分子量可以为1×104至6×105Da,优选为2×104至4×105Da。In step 1, the molecular weight of the low molecular weight polysaccharide may be 1×10 4 to 6×10 5 Da, preferably 2×10 4 to 4×10 5 Da.

所述氢氧化钠水溶液的质量浓度可以为0.5wt%至3wt%,优选0.5wt%至2wt%;The mass concentration of the sodium hydroxide aqueous solution can be 0.5wt% to 3wt%, preferably 0.5wt% to 2wt%;

所述透明质酸钠在氢氧化钠水溶液中的质量浓度可以为10wt%~30wt%,优选12wt%~25wt%。The mass concentration of the sodium hyaluronate in the sodium hydroxide aqueous solution may be 10 wt % to 30 wt %, preferably 12 wt % to 25 wt %.

所述的交联剂为1,4-丁二醇二缩水甘油醚(BDDE)、1-(2,3-环氧丙基)-2,3-环氧环己烷和1,2-乙二醇二缩水甘油醚中的一种。The crosslinking agent is one of 1,4-butanediol diglycidyl ether (BDDE), 1-(2,3-epoxypropyl)-2,3-epoxycyclohexane and 1,2-ethylene glycol diglycidyl ether.

步骤1中,所述交联剂与透明质酸钠和低分子多糖总和的质量比可以为1:(5~50),优选为1:(5~40)。In step 1, the mass ratio of the cross-linking agent to the sum of sodium hyaluronate and low molecular weight polysaccharide can be 1:(5-50), preferably 1:(5-40).

在某些实施例中,所述制备方法还包括:将得到的凝胶切割成小块,用PBS缓冲溶液浸泡,反复更换PBS缓冲溶液,直至凝胶呈无色;再通过160目筛网将凝胶筛分成凝胶小颗粒,再机械均质,制备得到多糖透明质酸钠复合凝胶。In certain embodiments, the preparation method further comprises: cutting the obtained gel into small pieces, soaking them in PBS buffer solution, repeatedly replacing the PBS buffer solution until the gel becomes colorless; then sieving the gel into small gel particles through a 160-mesh sieve, and then mechanically homogenizing to prepare a polysaccharide sodium hyaluronate composite gel.

在某些实施例中,所述制备方法还包括:将得到的凝胶切割成小块,用含盐酸的PBS缓冲溶液浸泡,反复更换PBS缓冲溶液,直至凝胶小块呈无色;再通过160目筛网将凝胶筛分成凝胶小颗粒,再机械均质,制备得到多糖透明质酸钠复合凝胶。In certain embodiments, the preparation method further comprises: cutting the obtained gel into small pieces, soaking them in a PBS buffer solution containing hydrochloric acid, repeatedly replacing the PBS buffer solution until the gel pieces are colorless; then sieving the gel into small gel particles through a 160-mesh sieve, and then mechanically homogenizing to prepare a polysaccharide sodium hyaluronate composite gel.

所述PBS缓冲溶液可以由氯化钠、磷酸氢二钠、磷酸二氢钠、盐酸和水配制而成。The PBS buffer solution can be prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, hydrochloric acid and water.

所述PBS缓冲溶液的pH可以为6.5~7.5。在某些实施例中,所述PBS缓冲溶液的pH为6.5~6.8。The pH of the PBS buffer solution may be 6.5 to 7.5. In certain embodiments, the pH of the PBS buffer solution is 6.5 to 6.8.

在某些实施例中,所述PBS缓冲溶液由氯化钠、磷酸氢二钠、磷酸二氢钠、盐酸和水配制而成,pH为6.5~7.0。In certain embodiments, the PBS buffer solution is prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, hydrochloric acid and water, and has a pH of 6.5-7.0.

在某些实施例中,所述PBS缓冲溶液由氯化钠、磷酸氢二钠、磷酸二氢钠和水配制而成,pH为7.0~7.5。In certain embodiments, the PBS buffer solution is prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate and water, and has a pH of 7.0 to 7.5.

根据本发明,作为优选方案,反复更换PBS缓冲溶液的次数为4~8次。According to the present invention, as a preferred embodiment, the PBS buffer solution is repeatedly replaced 4 to 8 times.

根据本发明,所述凝胶中,多糖和透明质酸钠的总浓度可以为20mg/mL~30mg/mL。在某些实施例中,所述凝胶中,多糖和透明质酸钠的总浓度为20mg/mL~25mg/mL。According to the present invention, the total concentration of polysaccharide and sodium hyaluronate in the gel may be 20 mg/mL to 30 mg/mL. In certain embodiments, the total concentration of polysaccharide and sodium hyaluronate in the gel is 20 mg/mL to 25 mg/mL.

根据本发明,所述多糖透明质酸钠复合凝胶可以被注射使用。所述多糖透明质酸钠复合凝胶可适宜地用于分离、替代或填充生物组织,或增加所述组织的体积,或用于填充皱纹、掩饰疤痕、或增加嘴唇体积的医美目的。According to the present invention, the polysaccharide sodium hyaluronate composite gel can be injected for use. The polysaccharide sodium hyaluronate composite gel can be suitably used for separating, replacing or filling biological tissues, or increasing the volume of the tissues, or for the medical and aesthetic purposes of filling wrinkles, concealing scars, or increasing the volume of lips.

本发明提供的制备方法的优点主要在于:The advantages of the preparation method provided by the present invention are mainly:

1.本发明提供了一条全新的可工业化的用于制备多糖透明质酸钠复合凝胶的方法;本发明通过调节碱浓度、交联剂用量、体系酸碱度、温度、时间等因素,特别是冷交联与热交联相结合的多层次交联方式工艺条件,得到的凝胶在保持了优秀的生物相容性的同时结构更加紧密,交联度高,拥有更好的粘弹性,更强的耐酶解性。1. The present invention provides a new and industrially applicable method for preparing polysaccharide sodium hyaluronate composite gel; the present invention adjusts factors such as alkali concentration, crosslinking agent dosage, system pH, temperature, time, etc., especially the multi-level crosslinking process conditions combining cold crosslinking and hot crosslinking, so that the obtained gel has a tighter structure, a high degree of crosslinking, better viscoelasticity, and stronger resistance to enzymolysis while maintaining excellent biocompatibility.

2.本发明解决了长时间高温交联反应易导致原料产生降解、最终产品主要由交联的高分子短链组成、凝胶强度大大降低及低温交联反应的反应速度缓慢、得到的产物整体强度低、交联度更低的问题。2. The present invention solves the problems that long-term high-temperature cross-linking reaction easily leads to degradation of raw materials, the final product is mainly composed of cross-linked polymer short chains, the gel strength is greatly reduced, and the reaction speed of low-temperature cross-linking reaction is slow, the overall strength of the obtained product is low, and the degree of cross-linking is even lower.

本发明人通过大量的试验发现:采用本发明方法相对于单纯的低温交联凝胶强度提高了0.4至3.8倍,相对于单纯的高温交联凝胶强度提高了2至17倍,相较于常规方法具有显著优势。The inventors found through a large number of experiments that the method of the present invention increases the strength of the gel by 0.4 to 3.8 times compared with simple low-temperature cross-linking, and increases the strength of the gel by 2 to 17 times compared with simple high-temperature cross-linking, which has significant advantages over conventional methods.

3.本发明使用了低温交联与高温交联相结合的多层次交联方式。先低温交联(0℃至20℃),制备的凝胶致密,弹性好,硬度低;由于温度较低,凝胶化时间长,聚合体系内物质分布均匀,使得凝胶的拓扑结构完整,从而具有更好的弹性;低温交联,可在减少原料降解的情况下实现交联,使交联网络更能抵抗高温降解并同步实现进一步交联;再温度升高,原料与交联剂结合速率加快,使得交联度增加,凝胶硬度增高。所以,结合使用低温、高温交联,可得到粘弹性佳的复合凝胶,提高凝胶交联度和结构稳定性,同时增加凝胶的粘弹性及注射后的支撑力(采用先高温再低温工艺制备交联凝胶,会破坏HA大分子链的链长,使其失去高分子量的优势,在使用过程中影响产品的稳定性和耐久度。)本发明方法制备的复合凝胶较先热交联后冷交联方法制备的凝胶,其凝胶粘弹性提高了31.3%至114%,取得意料不到技术效果。3. The present invention uses a multi-level crosslinking method that combines low-temperature crosslinking with high-temperature crosslinking. First, low-temperature crosslinking (0°C to 20°C) is used to prepare a dense gel with good elasticity and low hardness; due to the low temperature, the gelation time is long, and the material distribution in the polymerization system is uniform, so that the topological structure of the gel is complete, thereby having better elasticity; low-temperature crosslinking can achieve crosslinking while reducing the degradation of the raw materials, so that the crosslinked network can better resist high-temperature degradation and achieve further crosslinking simultaneously; then the temperature rises, the rate of binding between the raw materials and the crosslinking agent is accelerated, so that the degree of crosslinking increases and the hardness of the gel increases. Therefore, by combining low-temperature and high-temperature crosslinking, a composite gel with good viscoelasticity can be obtained, the crosslinking degree and structural stability of the gel are improved, and the viscoelasticity of the gel and the supporting force after injection are increased (the preparation of crosslinked gel by high temperature and then low temperature process will destroy the chain length of the HA macromolecular chain, making it lose the advantage of high molecular weight, and affecting the stability and durability of the product during use.) The composite gel prepared by the method of the present invention is 31.3% to 114% higher than the gel prepared by the method of first hot crosslinking and then cold crosslinking, and an unexpected technical effect is achieved.

4.本发明人发现低温交联反应时间越长,原料越不易降解,且与交联剂接触时间越长,从而使反应程度提高,叠加高温进一步促进交联反应,制得强度高、但推挤力有所降低的凝胶,有利于凝胶的注射使用。同时,经过实验确定了条件温和、原料降解程度低、产品强度高的反应条件,使所述制备方法适合进一步工业生产实施。4. The inventors found that the longer the low-temperature cross-linking reaction time, the less likely the raw material is to degrade, and the longer the contact time with the cross-linking agent, the higher the degree of reaction. The high temperature further promotes the cross-linking reaction, and a gel with high strength but reduced pushing force is obtained, which is conducive to the injection of the gel. At the same time, the reaction conditions with mild conditions, low degree of raw material degradation and high product strength were determined through experiments, making the preparation method suitable for further industrial production implementation.

5.本发明提供的方法,重现性好,适合不同类型多糖透明质酸钠复合凝胶的制备。本发明摸索出反应温度范围及反应时间与多糖透明质酸钠复合凝胶强度的关系,能以最简单的操作、最快的时间得到弹性好且易注射的凝胶产品。5. The method provided by the present invention has good reproducibility and is suitable for the preparation of different types of polysaccharide sodium hyaluronate composite gels. The present invention explores the relationship between the reaction temperature range and reaction time and the strength of the polysaccharide sodium hyaluronate composite gel, and can obtain a gel product with good elasticity and easy injection with the simplest operation and the fastest time.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

图1为实施例5中20wt%HA原料在10℃和40℃依次静置48h、3h的分子量变化图;FIG1 is a graph showing the molecular weight change of a 20 wt% HA raw material in Example 5 after being allowed to stand at 10° C. and 40° C. for 48 h and 3 h, respectively;

图2为实施例5中20wt%HA原料在40℃依次静置27h的分子量变化图;FIG2 is a graph showing the molecular weight change of 20 wt% HA raw materials in Example 5 after being allowed to stand at 40° C. for 27 h;

图3为实施例5中5wt%CS原料在40℃静置22h的分子量变化图;FIG3 is a graph showing the molecular weight change of a 5 wt% CS raw material in Example 5 after standing at 40° C. for 22 h;

各附图中,WDa表示万道尔顿。In the drawings, WDa stands for ten thousand Daltons.

具体实施方式DETAILED DESCRIPTION

下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件进行。The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples where specific conditions are not specified are usually carried out under normal conditions.

实施例中所用的原料或试剂除特别说明之外,均市售可得。Unless otherwise specified, the raw materials and reagents used in the examples are commercially available.

实施例中所述的室温在20℃~30℃。除非特别指出,所述的试剂不经纯化直接使用。所有溶剂均购自商业化供应商,例如奥德里奇(Aldrich),并且不经处理就可使用。The room temperature described in the examples is 20° C. to 30° C. Unless otherwise specified, the reagents were used directly without purification. All solvents were purchased from commercial suppliers, such as Aldrich, and were used without treatment.

实施例1:低温、高温和反应时间对HA/CS复合凝胶粘弹性的影响Example 1: Effects of low temperature, high temperature and reaction time on the viscoelasticity of HA/CS composite gel

在搅拌状态下将透明质酸钠(HA)(分子量为2.3×106Da,4.0g)粉末缓慢加入1wt%NaOH水溶液(20mL)中,待溶解均匀后,缓慢加入硫酸软骨素(CS)(6.5×104Da,1.0g),搅拌均匀至浅黄色透明状;向上述溶液中加入1,4-丁二醇二缩水甘油醚(BDDE)(0.36g),搅拌30min后转入Y1℃水浴中反应X1h;低温反应结束后转入Y2℃水浴中继续交联X2h,得到浅黄色块状凝胶。Sodium hyaluronate (HA) (molecular weight 2.3×10 6 Da, 4.0 g) powder was slowly added to 1wt% NaOH aqueous solution (20 mL) under stirring. After being uniformly dissolved, chondroitin sulfate (CS) (6.5×10 4 Da, 1.0 g) was slowly added and stirred evenly until it became light yellow and transparent. 1,4-Butanediol diglycidyl ether (BDDE) (0.36 g) was added to the above solution, stirred for 30 min, and then transferred to a Y 1 ℃ water bath for reaction for X 1 h. After the low-temperature reaction was completed, it was transferred to a Y 2 ℃ water bath for continued cross-linking for X 2 h to obtain a light yellow block gel.

将得到的块状凝胶切割成1cm3左右的小块,用含盐酸的PBS缓冲溶液(pH 6.8)浸泡凝胶,中和其中的氢氧化钠。之后不断更换PBS缓冲溶液(pH 6.5~7.5),直至最终的凝胶小块呈无色。通过160目筛网将溶胀凝胶筛分成凝胶小颗粒,再经过机械均质,得到HA/CS复合交联凝胶产品,HA/CS总浓度及交联度如表1所示。The obtained block gel was cut into small pieces of about 1 cm3, and the gel was soaked in a PBS buffer solution (pH 6.8) containing hydrochloric acid to neutralize the sodium hydroxide therein. The PBS buffer solution (pH 6.5-7.5) was then continuously replaced until the final gel pieces were colorless. The swollen gel was sieved into small gel particles through a 160-mesh sieve, and then mechanically homogenized to obtain a HA/CS composite cross-linked gel product. The total HA/CS concentration and cross-linking degree are shown in Table 1.

将制备得到的HA/CS交联凝胶通过30G针头挤出,测试平均推挤力;将实验凝胶降解后检测1H NMR,通过BDDE及HA/CS双糖单元特征峰计算交联度(R=BDDE摩尔数/(HA/CS双糖单元总摩尔数);将实验凝胶放在旋转流变仪上,在平板模式下,固定应变为0.01%,选择频率扫描(0.01Hz~100Hz),测试凝胶在0.1Hz处的粘弹性,测试结果如表1所示。The prepared HA/CS cross-linked gel was extruded through a 30G needle to test the average pushing force; the experimental gel was degraded and tested for 1 H NMR, and the degree of cross-linking (R = BDDE molar number/(total molar number of HA/CS disaccharide units) was calculated by the characteristic peaks of BDDE and HA/CS disaccharide units; the experimental gel was placed on a rotational rheometer, in the plate mode, with a fixed strain of 0.01%, and a frequency sweep (0.01 Hz to 100 Hz) was selected to test the viscoelasticity of the gel at 0.1 Hz. The test results are shown in Table 1.

表1实施例1工艺条件及凝胶性能Table 1 Process conditions and gel properties of Example 1

由表1结果可知,实施例1-5、1-8至1-12相对于其他实施例凝胶强度提高了24.8%至305%,平均推挤力降低了11.4%至43.4%;低温反应时间越长,原料越不易降解,且与交联剂接触时间越长,反应程度提高,叠加高温进一步促进交联反应,使凝胶强度越高,推挤力也有所降低;在相同的低温反应时间下,30℃、5h反应条件更加温和,原料降解程度低,在较长反应时间下,可制备强度更高的凝胶样品。From the results in Table 1, it can be seen that the gel strength of Examples 1-5, 1-8 to 1-12 is improved by 24.8% to 305% compared with other examples, and the average pushing force is reduced by 11.4% to 43.4%; the longer the low-temperature reaction time, the less likely the raw material is to degrade, and the longer the contact time with the cross-linking agent, the higher the degree of reaction, and the high temperature further promotes the cross-linking reaction, so that the gel strength is higher and the pushing force is also reduced; under the same low-temperature reaction time, the reaction conditions of 30°C and 5h are milder, the degree of degradation of the raw material is low, and a gel sample with higher strength can be prepared under a longer reaction time.

实施例2:低分子多糖的种类和分子量对HA复合凝胶性能的影响Example 2: Effects of the type and molecular weight of low molecular weight polysaccharides on the properties of HA composite gel

将透明质酸钠(分子量为2.3×106Da,4.0g)粉末加入到1wt%NaOH溶液(20mL)中,待透明质酸钠溶解均匀后,缓慢加入1g低分子多糖,搅拌均匀至浅黄色透明状,加入BDDE(0.36g),搅拌30min后,先在10℃反应48h,再在40℃反应3h,得到浅黄色块状凝胶。将得到的块状凝胶切割成1cm3左右的小块,用含盐酸的PBS缓冲溶液(pH 6.8)浸泡凝胶,中和其中的氢氧化钠。之后不断更换PBS缓冲溶液(pH 6.5~7.5),直至最终的凝胶小块呈无色。通过160目筛网将溶胀凝胶筛分成凝胶小颗粒,再经过机械均质,得到高分子量HA/低分子多糖复合交联凝胶产品,高分子量HA/低分子多糖总浓度如表2所示。Sodium hyaluronate (molecular weight 2.3×10 6 Da, 4.0g) powder was added to 1wt% NaOH solution (20mL). After the sodium hyaluronate was evenly dissolved, 1g of low molecular weight polysaccharide was slowly added, stirred evenly until it was light yellow and transparent, BDDE (0.36g) was added, stirred for 30min, first reacted at 10°C for 48h, and then reacted at 40°C for 3h to obtain a light yellow block gel. The obtained block gel was cut into small pieces of about 1cm 3 , and the gel was soaked in a PBS buffer solution (pH 6.8) containing hydrochloric acid to neutralize the sodium hydroxide therein. After that, the PBS buffer solution (pH 6.5-7.5) was continuously replaced until the final gel block was colorless. The swollen gel was sieved into small gel particles through a 160-mesh sieve, and then mechanically homogenized to obtain a high molecular weight HA/low molecular weight polysaccharide composite cross-linked gel product. The total concentration of high molecular weight HA/low molecular weight polysaccharide is shown in Table 2.

将实施例2制备的高分子量HA/低分子多糖交联凝胶通过30G针头挤出,测试平均推挤力;将实验凝胶降解后检测1H NMR,通过BDDE及HA/低分子多糖双糖单元特征峰计算交联度(R=BDDE摩尔数/(HA/低分子多糖双糖单元的总摩尔数);将实验凝胶放在旋转流变仪上,在平板模式下,选择频率扫描(0.01Hz~100Hz),测试凝胶在0.1Hz处的粘弹性,测试结果如表2所示。The high molecular weight HA/low molecular weight polysaccharide cross-linked gel prepared in Example 2 was extruded through a 30G needle to test the average pushing force; the experimental gel was degraded and tested for 1 H NMR, and the degree of cross-linking (R = BDDE molar number/(total molar number of HA/low molecular weight polysaccharide disaccharide units) was calculated through the characteristic peaks of BDDE and HA/low molecular weight polysaccharide disaccharide units; the experimental gel was placed on a rotational rheometer, and in the flat plate mode, frequency scanning (0.01 Hz to 100 Hz) was selected to test the viscoelasticity of the gel at 0.1 Hz. The test results are shown in Table 2.

表2实施例2工艺条件及凝胶性能Table 2 Process conditions and gel properties of Example 2

由表2结果可知,与实施例1-5相比,在相同条件下,低分子HA的引入使得复合交联凝胶的强度降低,推挤力提高;而软骨素与硫酸软骨素对复合交联凝胶性能的贡献差别较小。整体上,随低分子多糖的分子量提高,凝胶强度提高,推挤力提高;对低分子多糖的种类而言,与低分子HA相比,添加C、CS使复合交联凝胶推挤力略有降低。From the results in Table 2, it can be seen that compared with Examples 1-5, under the same conditions, the introduction of low molecular weight HA reduces the strength of the composite cross-linked gel and increases the pushing force; while the contribution of chondroitin and chondroitin sulfate to the performance of the composite cross-linked gel is relatively small. Overall, as the molecular weight of the low molecular weight polysaccharide increases, the gel strength increases and the pushing force increases; for the types of low molecular weight polysaccharides, compared with low molecular weight HA, the addition of C and CS slightly reduces the pushing force of the composite cross-linked gel.

实施例3:透明质酸钠浓度对HA复合凝胶性能的影响Example 3: Effect of Sodium Hyaluronate Concentration on the Properties of HA Composite Gel

将透明质酸钠(分子量为2.3×106Da,2.4g)或透明质酸钠(分子量为2.3×106Da,3.2g)粉末将入到1wt%NaOH溶液(20mL)中,待透明质酸钠溶解均匀后,缓慢加入低分子多糖,如L-HA(分子量为4.6×104Da,0.6g)或硫酸软骨素(分子量为6.5×104Da,0.8g),搅拌均匀至透明状,对应加入BDDE(0.22g或0.29g),搅拌30min后,先在10℃反应48h,再在40℃反应3h,得到浅黄色块状凝胶。将得到的块状凝胶切割成1cm3左右的小块,用含盐酸的PBS缓冲溶液(pH 6.5)浸泡凝胶,中和其中的氢氧化钠。之后不断更换PBS缓冲溶液(pH 6.5~7.5),直至最终的凝胶小块呈无色。通过160目筛网将溶胀凝胶筛分成凝胶小颗粒,再经过机械均质,得到高分子量HA/低分子多糖复合交联凝胶产品,高分子量HA/低分子多糖总浓度及交联度如表3所示。Sodium hyaluronate (molecular weight 2.3×10 6 Da, 2.4g) or sodium hyaluronate (molecular weight 2.3×10 6 Da, 3.2g) powder was added to 1wt% NaOH solution (20mL). After sodium hyaluronate was evenly dissolved, low molecular weight polysaccharide, such as L-HA (molecular weight 4.6×10 4 Da, 0.6g) or chondroitin sulfate (molecular weight 6.5×10 4 Da, 0.8g) was slowly added, stirred evenly until transparent, BDDE (0.22g or 0.29g) was added accordingly, stirred for 30min, reacted at 10℃ for 48h, and then reacted at 40℃ for 3h to obtain a light yellow block gel. The obtained block gel was cut into small pieces of about 1cm 3 , and the gel was soaked in a PBS buffer solution (pH 6.5) containing hydrochloric acid to neutralize the sodium hydroxide therein. After that, the PBS buffer solution (pH 6.5-7.5) was continuously replaced until the final gel pieces were colorless. The swollen gel was sieved into gel particles through a 160-mesh sieve, and then mechanically homogenized to obtain a high molecular weight HA/low molecular weight polysaccharide composite cross-linked gel product. The total concentration and cross-linking degree of high molecular weight HA/low molecular weight polysaccharide are shown in Table 3.

将实施例3制备的高分子量HA/低分子多糖交联凝胶通过30G针头挤出,测试平均推挤力;将实验凝胶降解后检测1H NMR,通过BDDE及HA/低分子多糖双糖单元特征峰计算交联度(R=BDDE摩尔数/(HA/低分子多糖双糖单元的总摩尔数);将实验凝胶放在旋转流变仪上,在平板模式下,选择频率扫描(0.01Hz~100Hz),测试凝胶在0.1Hz处的粘弹性,测试结果如表3所示。The high molecular weight HA/low molecular weight polysaccharide cross-linked gel prepared in Example 3 was extruded through a 30G needle to test the average pushing force; the experimental gel was degraded and tested for 1 H NMR, and the degree of cross-linking (R = BDDE molar number/(total molar number of HA/low molecular weight polysaccharide disaccharide units) was calculated through the characteristic peaks of BDDE and HA/low molecular weight polysaccharide disaccharide units; the experimental gel was placed on a rotational rheometer, and in the flat plate mode, frequency scanning (0.01 Hz to 100 Hz) was selected to test the viscoelasticity of the gel at 0.1 Hz. The test results are shown in Table 3.

表3实施例3工艺条件及凝胶性能Table 3 Process conditions and gel properties of Example 3

由表3结果可知,随高分子量HA浓度增加,凝胶强度提高;在较低HA浓度下,与L-HA相比,CS对复合交联凝胶推挤力的降低程度更明显,在产品使用过程中更易推挤。From the results in Table 3, it can be seen that with the increase of high molecular weight HA concentration, the gel strength increases; at lower HA concentrations, compared with L-HA, CS has a more obvious reduction in the pushing force of the composite cross-linked gel, making it easier to push during product use.

实施例4:HA与CS比例对HA/CS复合凝胶粘弹性的影响Example 4: Effect of the ratio of HA to CS on the viscoelasticity of HA/CS composite gel

在搅拌状态下将透明质酸钠(4.0g,2.3×106Da)粉末缓慢加入1wt%NaOH溶液(20mL)中,待溶解均匀后,缓慢加入硫酸软骨素(CS,6.5×104Da),搅拌均匀至浅黄色透明状,再向上述溶液加入BDDE,均匀搅拌30min后,分别在10℃/24h+30℃/5h和10℃/48h+40℃/3h,得到浅黄色块状凝胶。将得到的块状凝胶切割成1cm3左右的小块,用含盐酸的PBS缓冲溶液(pH 6.5)浸泡凝胶,中和其中的氢氧化钠。之后不断更换PBS缓冲溶液(pH 6.5~7.5),直至最终的凝胶小块呈无色。通过160目筛网将溶胀凝胶筛分成凝胶小颗粒,再经过机械均质,得到HA/CS复合交联凝胶产品,HA/CS总浓度如表4所示。Under stirring, sodium hyaluronate (4.0 g, 2.3 × 10 6 Da) powder was slowly added to 1wt% NaOH solution (20 mL). After being uniformly dissolved, chondroitin sulfate (CS, 6.5 × 10 4 Da) was slowly added and stirred evenly until it was light yellow and transparent. Then BDDE was added to the above solution and stirred evenly for 30 minutes. Then, light yellow block gel was obtained at 10℃/24h+30℃/5h and 10℃/48h+40℃/3h, respectively. The obtained block gel was cut into small pieces of about 1 cm 3 , and the gel was soaked in PBS buffer solution (pH 6.5) containing hydrochloric acid to neutralize the sodium hydroxide therein. After that, the PBS buffer solution (pH 6.5-7.5) was continuously replaced until the final gel block was colorless. The swollen gel was sieved into small gel particles through a 160-mesh sieve, and then mechanically homogenized to obtain a HA/CS composite cross-linked gel product. The total concentration of HA/CS is shown in Table 4.

将实施例4制备的HA/CS交联凝胶通过30G针头挤出,测试平均推挤力;将实验凝胶降解后检测1HNMR,通过BDDE及HA/CS双糖单元特征峰计算交联度(R=BDDE摩尔数/(HA/CS双糖单元总摩尔数);将实验凝胶放在旋转流变仪上,在平板模式下,选择频率扫描(0.01~100Hz),测试凝胶在0.1Hz处的粘弹性,测试结果如表4所示。The HA/CS cross-linked gel prepared in Example 4 was extruded through a 30G needle to test the average pushing force; the experimental gel was degraded and tested for 1 HNMR, and the degree of cross-linking (R = BDDE molar number/(total HA/CS disaccharide unit molar number) was calculated by the characteristic peaks of BDDE and HA/CS disaccharide units; the experimental gel was placed on a rotational rheometer, and in the flat plate mode, a frequency scan (0.01-100 Hz) was selected to test the viscoelasticity of the gel at 0.1 Hz. The test results are shown in Table 4.

表4实施例4工艺条件及凝胶性能Table 4 Process conditions and gel properties of Example 4

由表4结果可知,随硫酸软骨素比例增加,凝胶强度逐渐提高,推挤力逐渐降低,说明在制备HA复合交联凝胶时,CS具有同时提高强度和助推挤的作用。From the results in Table 4, it can be seen that with the increase of the proportion of chondroitin sulfate, the gel strength gradually increases and the pushing force gradually decreases, indicating that when preparing HA composite cross-linked gel, CS has the effect of simultaneously improving strength and promoting pushing.

实施例5:HA原料在不同交联温度条件下的分子量(单位:万道尔顿)变化Example 5: Changes in molecular weight (unit: ten thousand Daltons) of HA raw materials under different crosslinking temperature conditions

表5 20wt%HA原料在10℃和40℃依次静置48h、3h的分子量变化Table 5 Molecular weight changes of 20wt% HA raw materials after standing at 10℃ and 40℃ for 48h and 3h respectively

表6 20wt%HA原料在40℃静置27h的分子量变化Table 6 Molecular weight change of 20wt% HA raw material at 40℃ for 27h

表7 5wt%CS原料在40℃静置22h的分子量变化Table 7 Molecular weight change of 5wt% CS raw material at 40℃ for 22h

由表5可知,HA原料在低温静置20h~48h内,分子量降低较少,由209万道尔顿分别降低至166万道尔顿、146万道尔顿。特别的是,HA在低温静置48h后再转入高温静置,3h后,HA分子量降低的更少,只降低至91万道尔顿(38%,相对于低温静置后的分子量而言)。以上结果表明,低温时间越长,原料在静置过程中发生的物理缠结越多,在后续高温交联过程中抵抗降解的能力更强。As shown in Table 5, the molecular weight of HA raw materials decreased less within 20h to 48h of low-temperature standing, from 2.09 million Daltons to 1.66 million Daltons and 1.46 million Daltons respectively. In particular, after HA was placed at low temperature for 48h and then transferred to high-temperature standing, after 3h, the molecular weight of HA decreased even less, only to 910,000 Daltons (38%, relative to the molecular weight after low-temperature standing). The above results show that the longer the low-temperature time, the more physical entanglements the raw materials will undergo during the standing process, and the stronger the ability to resist degradation in the subsequent high-temperature cross-linking process.

由表6可知,HA原料在高温静置3h后,分子量直接降低至82万道尔顿(61%),此时再进行低温静置,分子量只会继续缓慢下降,比先低温再高温静置的降解程度更多;在连续高温静置27h后,HA分子量已降至15万道尔顿,失去其高分子量的优势。As shown in Table 6, after the HA raw material was left at high temperature for 3 hours, the molecular weight directly decreased to 820,000 Daltons (61%). If it is left at low temperature again, the molecular weight will only continue to decrease slowly, which is more degraded than the case where it was left at low temperature first and then at high temperature. After being left at high temperature for 27 hours, the molecular weight of HA has dropped to 150,000 Daltons, losing its advantage of high molecular weight.

综上所述,与先进行低温静置再进行高温静置的原料相比,HA原料在高温静置后,分子量均降低至80万道尔顿~90万道尔顿,但先进行低温静置的原料在此过程中会发生不同程度的物理缠结,对高温有一定的抵抗作用,而不会发生高温直接将大分子链破坏成短链的情况。在添加化学交联剂的情况下,更容易得到物理、化学共交联的长链分子,制备稳定性更高、更耐久的HA/CS交联凝胶。In summary, compared with the raw materials that were first placed at low temperature and then at high temperature, the molecular weight of the HA raw materials after high temperature placement was reduced to 800,000 Daltons to 900,000 Daltons, but the raw materials that were first placed at low temperature would undergo varying degrees of physical entanglement during this process, and have a certain resistance to high temperature, and the high temperature would not directly destroy the macromolecular chain into short chains. When a chemical crosslinking agent is added, it is easier to obtain physically and chemically co-crosslinked long-chain molecules and prepare HA/CS crosslinked gels with higher stability and durability.

对比例1:低温交联工艺条件对发明凝胶粘弹性的影响Comparative Example 1: Effect of low temperature cross-linking process conditions on the viscoelasticity of the inventive gel

按照实施例1操作,其中X1、Y1、X2、Y2见表8。The operation was carried out according to Example 1, wherein X 1 , Y 1 , X 2 , and Y 2 are shown in Table 8.

对比例2:高温交联工艺条件对发明凝胶粘弹性的影响Comparative Example 2: Effect of high temperature cross-linking process conditions on the viscoelasticity of the inventive gel

按照实施例1操作,其中X1、Y1、X2、Y2见表8。The operation was carried out according to Example 1, wherein X 1 , Y 1 , X 2 , and Y 2 are shown in Table 8.

表8对比例1至2工艺条件及凝胶性能Table 8 Process conditions and gel properties of Comparative Examples 1 to 2

结合表1和表2可以看出:实施例1-5、1-8至1-12相对于对比例1-1至1-4凝胶强度提高了44.1%至376.5%,实施例1-5、1-8至1-12相对于对比例2-1至2-4凝胶强度提高了210.3%至1718%;由表2结果可知,对比例1-1至1-4制备的凝胶,随反应时间增加,凝胶强度提高,与实施例1相比,整体强度低,交联度也更低;对比例2-1至2-4制备的凝胶交联度增加,凝胶颜色呈黄褐色,但相对于实施例1的凝胶强度降低程度更多。Combining Table 1 and Table 2, it can be seen that the gel strength of Examples 1-5 and 1-8 to 1-12 is increased by 44.1% to 376.5% relative to that of Comparative Examples 1-1 to 1-4, and the gel strength of Examples 1-5 and 1-8 to 1-12 is increased by 210.3% to 1718% relative to that of Comparative Examples 2-1 to 2-4; from the results in Table 2, it can be seen that the gels prepared in Comparative Examples 1-1 to 1-4 have improved gel strength as the reaction time increases, and compared with Example 1, the overall strength is low and the degree of crosslinking is also lower; the gels prepared in Comparative Examples 2-1 to 2-4 have increased crosslinking degrees and are yellow-brown in color, but the gel strength is reduced more than that in Example 1.

对比例3:采用先高温再低温工艺制备HA/CS交联凝胶Comparative Example 3: Preparation of HA/CS cross-linked gel by high temperature followed by low temperature process

本对比例考察在与实施例1相同的透明质酸钠浓度、分子量、透明质酸钠与硫酸软骨素比例、交联剂用量和碱性条件下,参考专利CN112812330B凝胶制备工艺,考察样品先在交联反应温度40℃下反应3h,之后再将凝胶转移至10℃下反应24h/48h,凝胶粘弹性的变化。This comparative example investigates the changes in the viscoelasticity of the gel under the same sodium hyaluronate concentration, molecular weight, ratio of sodium hyaluronate to chondroitin sulfate, amount of cross-linking agent and alkaline conditions as in Example 1, with reference to the gel preparation process of patent CN112812330B, and investigates the changes in the viscoelasticity of the gel after the sample is first reacted at a cross-linking reaction temperature of 40°C for 3h and then the gel is transferred to 10°C for reaction for 24h/48h.

表9对比例3工艺条件及凝胶性能Table 9 Process conditions and gel properties of comparative example 3

采用先高温再低温工艺制备HA/CS交联凝胶可以提高凝胶强度和交联度,但原料降解数据表明,先高温会破坏HA大分子链的链长,使其断裂成较短的链。该方法制备得到的凝胶弹性模量与低温24h/48h再高温交联3h凝胶的弹性模量相比无优势,但失去了分子高分子量的优势,在使用过程中会影响产品的稳定性和耐久度。The preparation of HA/CS cross-linked gel by high temperature first and then low temperature process can improve gel strength and cross-linking degree, but the raw material degradation data shows that high temperature first will destroy the chain length of HA macromolecular chain and break it into shorter chains. The elastic modulus of the gel prepared by this method has no advantage over the elastic modulus of the gel prepared by low temperature for 24h/48h and then high temperature cross-linking for 3h, but it loses the advantage of high molecular weight of the molecule, which will affect the stability and durability of the product during use.

Claims (10)

1.一种多糖透明质酸钠复合凝胶的制备方法,其特征在于包含以下步骤:将透明质酸钠溶于氢氧化钠水溶液,再加入低分子多糖,然后加入交联剂,先在温度A反应24h~72h,再在温度B交联反应1h~6h,制备得到多糖透明质酸钠复合凝胶;其中,所述的低分子多糖为透明质酸钠、硫酸软骨素、软骨素、肝素和纤维素中的一种或多种;所述的温度A为0℃~20℃;所述的温度B为25℃~50℃。1. A method for preparing a polysaccharide sodium hyaluronate composite gel, characterized in that it comprises the following steps: dissolving sodium hyaluronate in a sodium hydroxide aqueous solution, adding a low molecular weight polysaccharide, and then adding a cross-linking agent, first reacting at temperature A for 24h to 72h, and then cross-linking reacting at temperature B for 1h to 6h to prepare a polysaccharide sodium hyaluronate composite gel; wherein the low molecular weight polysaccharide is one or more of sodium hyaluronate, chondroitin sulfate, chondroitin, heparin and cellulose; the temperature A is 0°C to 20°C; the temperature B is 25°C to 50°C. 2.根据权利要求1所述的制备方法,其特征在于:所述温度A为5℃~15℃;和/或所述温度B为25℃~45℃。2. The preparation method according to claim 1, characterized in that: the temperature A is 5°C to 15°C; and/or the temperature B is 25°C to 45°C. 3.根据权利要求1所述的制备方法,其特征在于:在温度A反应36h~60h,和/或在温度B交联反应2h~5h。3. The preparation method according to claim 1 is characterized in that the reaction is carried out at temperature A for 36 hours to 60 hours, and/or the cross-linking reaction is carried out at temperature B for 2 hours to 5 hours. 4.根据权利要求1所述的制备方法,其特征在于:所述的低分子多糖为透明质酸钠、硫酸软骨素和软骨素中的一种或多种。4. The preparation method according to claim 1, characterized in that the low molecular weight polysaccharide is one or more of sodium hyaluronate, chondroitin sulfate and chondroitin. 5.根据权利要求1所述的制备方法,其特征在于:所述的交联剂为1,4-丁二醇二缩水甘油醚、1-(2,3-环氧丙基)-2,3-环氧环己烷和1,2-乙二醇二缩水甘油醚中的一种。5. The preparation method according to claim 1, characterized in that the cross-linking agent is one of 1,4-butanediol diglycidyl ether, 1-(2,3-epoxypropyl)-2,3-epoxycyclohexane and 1,2-ethylene glycol diglycidyl ether. 6.根据权利要求1所述的制备方法,其特征在于,包括以下条件中的至少之一:6. The preparation method according to claim 1, characterized in that it comprises at least one of the following conditions: 所述的透明质酸钠与低分子多糖的质量比为(1~9):1;The mass ratio of sodium hyaluronate to low molecular weight polysaccharide is (1-9):1; 所述透明质酸钠的分子量为1×106至3×106Da;The molecular weight of the sodium hyaluronate is 1×10 6 to 3×10 6 Da; 所述的低分子多糖的分子量为1×104至6×105Da;The molecular weight of the low molecular weight polysaccharide is 1×10 4 to 6×10 5 Da; 所述氢氧化钠水溶液的质量浓度为0.5wt%~3wt%;The mass concentration of the sodium hydroxide aqueous solution is 0.5wt% to 3wt%; 所述的透明质酸钠在氢氧化钠水溶液中的质量浓度为10wt%~30wt%;The mass concentration of the sodium hyaluronate in the sodium hydroxide aqueous solution is 10wt% to 30wt%; 所述的交联剂与透明质酸钠和低分子多糖总和的投料质量比为1:(5~50)。The mass ratio of the cross-linking agent to the total amount of sodium hyaluronate and low-molecular polysaccharide is 1:(5-50). 7.根据权利要求1所述的制备方法,其特征在于,包括以下条件中的至少之一:7. The preparation method according to claim 1, characterized in that it comprises at least one of the following conditions: 所述的透明质酸钠与低分子多糖的质量比为(1~6):1;The mass ratio of sodium hyaluronate to low molecular weight polysaccharide is (1-6):1; 所述透明质酸钠的分子量为2×106至3×106Da;The molecular weight of the sodium hyaluronate is 2×10 6 to 3×10 6 Da; 所述的低分子多糖的分子量为2×104至4×105Da;The molecular weight of the low molecular weight polysaccharide is 2×10 4 to 4×10 5 Da; 所述氢氧化钠水溶液的质量浓度为0.5wt%~2wt%;The mass concentration of the sodium hydroxide aqueous solution is 0.5wt% to 2wt%; 所述的透明质酸钠在氢氧化钠水溶液中的质量浓度为12wt%~25wt%;The mass concentration of the sodium hyaluronate in the sodium hydroxide aqueous solution is 12wt% to 25wt%; 所述的交联剂与透明质酸钠和低分子多糖总和的投料质量比为1:(5~40)。The mass ratio of the cross-linking agent to the total amount of sodium hyaluronate and low-molecular polysaccharide is 1:(5-40). 8.根据权利要求1-7任一所述的制备方法,其特征在于还包括:将得到的凝胶切割成小块,用含有盐酸的PBS缓冲溶液浸泡,中和其中的氢氧化钠;然后反复更换PBS缓冲溶液,直至凝胶小块呈无色;再通过160目筛网将凝胶筛分,再机械均质,制备得到多糖透明质酸钠复合凝胶产物;所述凝胶产物中,多糖和透明质酸钠的总浓度为20mg/mL~30mg/mL;所述PBS缓冲溶液由氯化钠、磷酸氢二钠、磷酸二氢钠、盐酸和水配制而成,pH为6.5~7.5。8. The preparation method according to any one of claims 1 to 7, characterized in that it also includes: cutting the obtained gel into small pieces, soaking them in a PBS buffer solution containing hydrochloric acid to neutralize the sodium hydroxide therein; then repeatedly replacing the PBS buffer solution until the gel pieces are colorless; then sieving the gel through a 160-mesh sieve, and then mechanically homogenizing to prepare a polysaccharide sodium hyaluronate composite gel product; in the gel product, the total concentration of polysaccharide and sodium hyaluronate is 20 mg/mL to 30 mg/mL; the PBS buffer solution is prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, hydrochloric acid and water, and has a pH of 6.5 to 7.5. 9.根据权利要求1-5任一所述的制备方法,其特征在于包含:9. The preparation method according to any one of claims 1 to 5, characterized in that it comprises: 将透明质酸钠溶于0.5wt%-2wt%氢氧化钠水溶液,再加入硫酸软骨素,然后加入交联剂1,4-丁二醇二缩水甘油醚,先在5℃~15℃反应48h~72h,再在25℃~45℃交联反应2h~5h,得到凝胶;其中,所述的透明质酸钠在氢氧化钠水溶液中的质量浓度为12wt%~20wt%;所述透明质酸钠与硫酸软骨素的投料质量比为(1~4):1;所述的交联剂与透明质酸钠和低分子多糖总和的投料质量比为1:(10~25);所述透明质酸钠的分子量为2×106Da至2.5×106Da;所述硫酸软骨素的分子量为3×104Da至1×105Da;Sodium hyaluronate is dissolved in a 0.5wt%-2wt% sodium hydroxide aqueous solution, chondroitin sulfate is added, and then a cross-linking agent 1,4-butanediol diglycidyl ether is added, and the mixture is first reacted at 5°C to 15°C for 48h to 72h, and then cross-linked at 25°C to 45°C for 2h to 5h to obtain a gel; wherein the mass concentration of the sodium hyaluronate in the sodium hydroxide aqueous solution is 12wt% to 20wt%; the mass ratio of the sodium hyaluronate to the chondroitin sulfate is (1 to 4):1; the mass ratio of the cross-linking agent to the sum of the sodium hyaluronate and the low molecular weight polysaccharide is 1:(10 to 25); the molecular weight of the sodium hyaluronate is 2×10 6 Da to 2.5×10 6 Da; the molecular weight of the chondroitin sulfate is 3×10 4 Da to 1×10 5 Da; 将得到的凝胶切割成小块,用PBS缓冲溶液浸泡,中和其中的氢氧化钠;然后反复更换PBS缓冲溶液,直至凝胶小块呈无色;再通过160目筛网将凝胶筛分成凝胶小颗粒,再机械均质,制备得到多糖透明质酸钠复合凝胶产物;所述凝胶产物中,多糖和透明质酸钠的总浓度为20mg/mL~30mg/mL;所述PBS缓冲溶液由氯化钠、磷酸氢二钠、磷酸二氢钠、盐酸和水配制而成,pH为6.5~7.5。The obtained gel is cut into small pieces, and soaked in PBS buffer solution to neutralize the sodium hydroxide therein; then the PBS buffer solution is repeatedly replaced until the gel pieces are colorless; then the gel is sieved into small gel particles through a 160-mesh sieve, and then mechanically homogenized to prepare a polysaccharide sodium hyaluronate composite gel product; in the gel product, the total concentration of polysaccharide and sodium hyaluronate is 20 mg/mL to 30 mg/mL; the PBS buffer solution is prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, hydrochloric acid and water, and has a pH of 6.5 to 7.5. 10.根据权利要求1-5任一所述的制备方法,其特征在于包含:10. The preparation method according to any one of claims 1 to 5, characterized in that it comprises: 将透明质酸钠溶于1wt%氢氧化钠水溶液,再加入硫酸软骨素,然后加入交联剂1,4-丁二醇二缩水甘油醚,先在8℃~12℃反应48h~72h,再在30℃~40℃交联反应2h~5h,得到凝胶;其中,所述的透明质酸钠在氢氧化钠水溶液中的质量浓度为16wt%~20wt%;所述透明质酸钠与硫酸软骨素的投料质量比为4:1;所述的交联剂与透明质酸钠和低分子多糖总和的投料质量比为1:(10~15);所述透明质酸钠的分子量为(2~2.5)×106Da;所述硫酸软骨素的分子量为(3~7)×104Da;Sodium hyaluronate is dissolved in a 1wt% sodium hydroxide aqueous solution, chondroitin sulfate is added, and then a cross-linking agent 1,4-butanediol diglycidyl ether is added, and the mixture is first reacted at 8°C to 12°C for 48h to 72h, and then cross-linked at 30°C to 40°C for 2h to 5h to obtain a gel; wherein the mass concentration of the sodium hyaluronate in the sodium hydroxide aqueous solution is 16wt% to 20wt%; the mass ratio of the sodium hyaluronate to the chondroitin sulfate is 4:1; the mass ratio of the cross-linking agent to the sum of the sodium hyaluronate and the low molecular weight polysaccharide is 1:(10-15); the molecular weight of the sodium hyaluronate is (2-2.5)×10 6 Da; the molecular weight of the chondroitin sulfate is (3-7)×10 4 Da; 将得到的凝胶切割成小块,用含有盐酸的pH为6.5~7.0的PBS缓冲溶液浸泡,中和其中的氢氧化钠;然后反复更换PBS缓冲溶液,直至凝胶小块呈无色;再通过160目筛网将凝胶筛分成凝胶小颗粒,再机械均质,制备得到多糖透明质酸钠复合凝胶产物;所述凝胶产物中,多糖和透明质酸钠的总浓度为20mg/mL~25mg/mL;所述PBS缓冲溶液由氯化钠、磷酸氢二钠、磷酸二氢钠、盐酸和水配制而成;更换用的PBS缓冲溶液的pH为6.5~7.5。The obtained gel is cut into small pieces, and soaked in a PBS buffer solution with a pH of 6.5 to 7.0 containing hydrochloric acid to neutralize the sodium hydroxide therein; then the PBS buffer solution is repeatedly replaced until the gel pieces are colorless; then the gel is sieved into small gel particles through a 160-mesh sieve, and then mechanically homogenized to prepare a polysaccharide sodium hyaluronate composite gel product; in the gel product, the total concentration of polysaccharide and sodium hyaluronate is 20 mg/mL to 25 mg/mL; the PBS buffer solution is prepared from sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, hydrochloric acid and water; the pH of the replacement PBS buffer solution is 6.5 to 7.5.
CN202410647177.4A 2024-05-23 2024-05-23 Preparation method of polysaccharide sodium hyaluronate composite gel Active CN118546395B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410647177.4A CN118546395B (en) 2024-05-23 2024-05-23 Preparation method of polysaccharide sodium hyaluronate composite gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410647177.4A CN118546395B (en) 2024-05-23 2024-05-23 Preparation method of polysaccharide sodium hyaluronate composite gel

Publications (2)

Publication Number Publication Date
CN118546395A true CN118546395A (en) 2024-08-27
CN118546395B CN118546395B (en) 2025-05-20

Family

ID=92445426

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410647177.4A Active CN118546395B (en) 2024-05-23 2024-05-23 Preparation method of polysaccharide sodium hyaluronate composite gel

Country Status (1)

Country Link
CN (1) CN118546395B (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194758A1 (en) * 2003-04-10 2006-08-31 Pierre Lebreton Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and dydrogels thus obtained
US20100261893A1 (en) * 2009-04-09 2010-10-14 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
CN103146003A (en) * 2013-03-06 2013-06-12 上海其胜生物制剂有限公司 Preparation method of low-temperature secondary cross-linked sodium hyaluronate gel
CN104225677A (en) * 2013-06-13 2014-12-24 山东省生物药物研究院 Cross-linked hyaluronic acid cell-scaffold material and preparation method and application
US20150328123A1 (en) * 2012-09-29 2015-11-19 Hangzhou Gallop Biological Products Co., Ltd. Cross-linked sodium hyaluronate gel for tissue filler for plastic surgery and preparation method thereof
US20170143870A1 (en) * 2014-04-01 2017-05-25 Merz Pharma Gmbh & Co. Kgaa Polysaccharide soft tissue fillers with improved persistence
CN107936272A (en) * 2017-11-27 2018-04-20 华熙福瑞达生物医药有限公司 A kind of preparation method of 3D cross-linked-hyaluronic acid salt gels for radiotherapy protection and products thereof
CN109513043A (en) * 2017-09-20 2019-03-26 刘宏飞 A kind of injection modification hyaluronic acid sodium gel and preparation method thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194758A1 (en) * 2003-04-10 2006-08-31 Pierre Lebreton Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and dydrogels thus obtained
US20100261893A1 (en) * 2009-04-09 2010-10-14 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
US20150328123A1 (en) * 2012-09-29 2015-11-19 Hangzhou Gallop Biological Products Co., Ltd. Cross-linked sodium hyaluronate gel for tissue filler for plastic surgery and preparation method thereof
CN103146003A (en) * 2013-03-06 2013-06-12 上海其胜生物制剂有限公司 Preparation method of low-temperature secondary cross-linked sodium hyaluronate gel
CN104225677A (en) * 2013-06-13 2014-12-24 山东省生物药物研究院 Cross-linked hyaluronic acid cell-scaffold material and preparation method and application
US20170143870A1 (en) * 2014-04-01 2017-05-25 Merz Pharma Gmbh & Co. Kgaa Polysaccharide soft tissue fillers with improved persistence
CN109513043A (en) * 2017-09-20 2019-03-26 刘宏飞 A kind of injection modification hyaluronic acid sodium gel and preparation method thereof
CN107936272A (en) * 2017-11-27 2018-04-20 华熙福瑞达生物医药有限公司 A kind of preparation method of 3D cross-linked-hyaluronic acid salt gels for radiotherapy protection and products thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YU XUE ET AL.: "Synthesis of hyaluronic acid hydrogels by crosslinking the mixture of high-molecular-weight hyaluronic acid and low-molecular-weight hyaluronic acid with 1, 4-butanediol diglycidyl Ether", RSC ADV., vol. 10, no. 12, 18 February 2020 (2020-02-18), pages 7206 - 7213, XP093116218, DOI: 10.1039/C9RA09271D *
赵乐军, 白硕佳, 曹红英, 奚廷斐: "透明质酸钠交联凝胶的制备", 透析与人工器官, no. 01, 30 March 2002 (2002-03-30), pages 46 - 48 *

Also Published As

Publication number Publication date
CN118546395B (en) 2025-05-20

Similar Documents

Publication Publication Date Title
US6734298B1 (en) Cross-linking process of carboxylated polysaccharides
CN103974722B (en) Water insoluble gel composition and method for preparing same
RU2692800C2 (en) Viscoelastic gels as novel fillers
US7651702B2 (en) Crosslinking hyaluronan and chitosanic polymers
JP5123285B2 (en) Acrylic hyaluronic acid
US11191870B2 (en) Gel of sodium hyaluronate cross-linked by polyethylene glycol epoxy derivative for injection and preparation method thereof
CN108014376A (en) A kind of polysaccharide hydrogel of the base-modified chitosan of beet and preparation method thereof
CN106279729A (en) A kind of cross-linking hyaluronic acid gel and preparation method and application
Li et al. In vitro and in vivo evaluation of 3D biodegradable thermo/pH sensitive sol-gel reversible hydroxybutyl chitosan hydrogel
CN106866998A (en) A kind of chitosan quaternary ammonium salt/carboxymethylcellulose calcium superabsorbent hydrogel and its preparation method and application
CN115429935B (en) Injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof
KR20210137345A (en) Crosslinked hyaluronic acid having high elasticity, high viscosity and high effective cross-linker ratio, and preparing method thereof
US12252594B2 (en) Method of preparing a hydrogel product
CN104231285A (en) Hyaluronic acid derivative gel and preparing method thereof
CN118546395A (en) Preparation method of polysaccharide sodium hyaluronate composite gel
CN112430334B (en) A high-strength shape-memory chitosan-based hydrogel and its preparation method and application
CN113683795A (en) Micro-crosslinked hyaluronic acid and preparation method thereof
CN114727912B (en) Cross-linked hyaluronic acid butyrate or butyrate-formate derivative and cross-linking method thereof
To et al. Synthesis and characterisation of biodegradable carboxymethyl cellulose microcarriers from oil palm empty fruit bunch for therapeutic applications
CN119859286A (en) Method for preparing polysaccharide sodium hyaluronate composite gel by pre-crosslinking method
CN118027454B (en) Crosslinked sodium hyaluronate gel for injection and preparation method thereof
CN119176959B (en) Hyaluronic acid-polylactic acid copolymer crosslinked gel and preparation method and application thereof
CN119978462A (en) Preparation method of collagen hyaluronic acid co-crosslinking gel
CN110023340A (en) The method for being crosslinked glycosaminoglycan
CN119455104A (en) Agarose gel implant with good injection performance

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant